Caricamento...
Double‐Blind, Randomized, Placebo‐Controlled Trial of DA‐9701 in Parkinson's Disease: PASS‐GI Study
OBJECTIVES: This study aimed to assess the efficacy of DA‐9701 on gastrointestinal symptom‐related quality of life in patients with Parkinson's disease on stable dopaminergic medications. METHODS: This multicenter, double‐blind, placebo‐controlled, phase 4 trial included a total of 144 patients...
Salvato in:
| Pubblicato in: | Mov Disord |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons, Inc.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7754502/ https://ncbi.nlm.nih.gov/pubmed/32761955 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.28219 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|